MMV ESAC member Dennis Smith recognized by the International Society for the Study of Xenobiotics 28 February 2023
Medicines for Malaria Venture and the Africa CDC sign Memorandum of Understanding to support African manufacturers 15 December 2022
WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester 28 November 2022
Strong recommendation for pyronaridine-artesunate in revised WHO Malaria Treatment Guidelines 25 November 2022
Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria 23 November 2022
First African-manufactured medicine to prevent malaria in pregnant women and infants quality-approved by WHO 25 August 2022
MMV and IVCC make 240 compounds available to stimulate research into new drugs and insecticides 13 August 2022
MMV announces the start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol 22 July 2022
MMV echoes Fight the Fakes Alliance’s call for Global Fund Replenishment to prevent increase in falsified medicines 14 July 2022
Pregnancy registries: providing crucial safety information on the use of drugs during pregnancy 6 July 2022
Nigeria: Expanding seasonal malaria chemoprevention and overcoming challenges posed by COVID-19 6 July 2022
This World Malaria Day MMV joins Swiss Malaria Group in calling for increased commitment to combatting malaria 22 April 2022